Core Viewpoint - XunCe (03317) has seen a significant increase in its stock price, rising over 16% to a high of 72 HKD, which is a 50% increase from its IPO price of 48 HKD [1] Group 1: Company Developments - XunCe announced a non-binding strategic cooperation framework agreement with Jin Yong Investment on January 13, aimed at advancing real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] - The collaboration also focuses on promoting innovation and commercialization of technology products related to wealth management [1] Group 2: Market Context - The review period for the Hang Seng Composite Index's semi-annual assessment ended on December 31, 2025, with a new round of adjustments to the Hong Kong Stock Connect list expected to be announced after the market closes on February 20, 2026, and implemented after the market closes on March 6, 2026 [1] - Longjiang Securities has published a report predicting that 47 stocks will meet the criteria for inclusion in the Hong Kong Stock Connect list, with XunCe likely to be among them [1]

Group 1 - The core viewpoint of the article highlights that Xunce (03317) has seen a significant stock price increase of over 16%, reaching a high of 72 HKD, which is a 50% rise from its IPO price of 48 HKD [1] - As of the report, the stock is trading at 70.5 HKD with a trading volume of 12.64 million HKD [1] - Xunce announced a non-binding strategic cooperation framework agreement with Jinyong Investment on January 13, aimed at advancing real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] Group 2 - The strategic cooperation also focuses on promoting innovation and commercialization of technology products related to wealth management [1] - The Hang Seng Composite Index's semi-annual review period ended on December 31, 2025, with a new adjustment to the Hong Kong Stock Connect list expected to be announced after the market closes on February 20, 2026, and implemented after the market closes on March 6, 2026 [1] - Longjiang Securities has published a report predicting that 47 stocks will meet the criteria for inclusion in the Hong Kong Stock Connect list, with Xunce likely to be among them [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 收購迅策股份 於2026年1月14日，本公司全資附屬公司Redwood通過於聯交所進行市場上交易以代 價總額約15,510,000港元（不包括交易成本）進一步收購235,000股迅策股份，即約每股 迅策股份66港元。 經考慮收購事項及於2025年1 2月2 4日的先前收購事項，Redwood以代價總額約 38,547,000港元（不包括交易成本）收購合共715,000股迅策股份，即約每股迅策股份54 港元。 該等收購事項後，本集團持有合共715,000股迅策股份，佔於本公告日期迅策已發行 股份總數約0.22%。 GOLDSTREAM INVESTMENT LIMITED 金涌投資有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1328） 自願公告 收購上市證券 茲提述本公司日期為2026年1月13日及2025年12月30日的該等公告，內容分別有關與迅 策訂立之戰略合作協議及認購迅策股份。 –1– ...

Major Events - Longi Technology (09611) plans to globally offer 52.2591 million H-shares from January 14 to January 19 [1] - CK Life Sciences (00013) announced the results of the SACHI III study published in The Lancet [1] - Dongyang Sunshine Pharmaceutical (06887) launched an AI-driven R&D platform targeting the PROTAC mechanism, continuing to deepen its AI strategic layout [1] - Dongyao Pharmaceutical-B (01875) received a cash offer from WuXi AppTec (02268) at a premium of approximately 99%, with resumption of trading on January 15 [1] - Valiant Pharmaceuticals-B (09887) received Fast Track designation from the US FDA for its bispecific antibody, Opalizumab (LBL-024) [1] - Xunqi (03317) entered into a strategic cooperation framework agreement with Jinyong Investment to support digital transformation in investment research, trading, and risk management [1] Operating Performance - CITIC Securities (06030) reported a net profit attributable to shareholders of 30.051 billion yuan for 2025, an increase of 38.46% year-on-year [1] - CITIC Bank (00998) reported a net profit attributable to shareholders of 70.618 billion yuan for 2025, a year-on-year increase of 2.98% [1] - China General Nuclear Power New Energy (01811) completed a cumulative power generation of 19,000 GWh in 2025, a decrease of 0.8% year-on-year [1] - Yuexiu Property (00123) reported a cumulative contract sales amount of approximately 106.21 billion yuan for 2025 [1] - WuXi AppTec (02268) issued a profit warning, expecting a net profit growth of over 38% year-on-year for 2025 [1] - Jinyu Group (02009) issued a profit warning, anticipating a net loss attributable to shareholders of 900 million to 1.2 billion yuan for 2025 [1] - Saijing Technology (00580) issued a profit alert, expecting a net profit increase of approximately 30.0% for 2025 [1] - Beijing Beichen Industrial Co., Ltd. (00588) issued a profit warning, expecting a net loss attributable to shareholders of 2.696 billion to 3.38 billion yuan for 2025 [1]

Group 1 - The stock of Tongdao Liepin (06100) rose by 10.17%, reflecting market recognition of its "AI recruitment strategy" and "financial stability" [1] - The restaurant sector saw significant gains, with Haidilao (06862) up 7.7%, Jiumaojiu (09922) up 5.38%, and Helens (09869) up 6.67%, driven by demand recovery since early 2023 [1] - Voice Technology (02495) surged over 10% after announcing a share issuance of 6.73 million shares at HKD 46.3 each, with approximately 50% of the proceeds allocated for R&D [1] Group 2 - Alibaba-W (09988) increased by nearly 5%, following announcements at the 2025 Cloud Summit regarding changes to hardware infrastructure in response to new market demands [1] - Hua Hong Semiconductor (01347) rose over 5.3% after announcing a plan to acquire approximately 97.5% of Huali Micro for CNY 8.268 billion [2] - Jiufang Zhitu Holdings (09636) saw an increase of nearly 8%, attributed to active market trading with a daily turnover reaching CNY 3.6 trillion [2] Group 3 - Jingtai Holdings (02228) rose over 5.5%, with a month-to-date increase of nearly 50%, following the successful dual approval of its incubated company ReviR's innovative drug RTX-117 [2] - Xun Ce (03317) briefly rose over 6%, reaching a new high of HKD 68, due to a strategic cooperation framework agreement with Jinyong Investment [2] - Alibaba Health (00241) surged over 14.2%, with a month-to-date increase exceeding 30%, following the announcement of a milestone solution in the infant vascular tumor treatment field [3] Group 4 - Bitcoin rose over 2.5%, reaching USD 93,500, with Bitcoin-related stocks also increasing, including MSTR up 6.63% and COIN up 4% [4] - GCDT, a green decarbonization technology company, saw its stock price surge 25% after its IPO, which aims to raise approximately USD 10 million for factory construction and debt repayment [4] - Lithium giant Albemarle (ALB.US) rose 4.46%, with analysts noting a reduction in concerns over its balance sheet as it achieves leverage optimization [4] Group 5 - Gold concept stocks showed mixed performance, with AngloGold Ashanti (AU.US) up 1.11% and Barrick Mining (B.US) up 1.39%, while some others declined [5] - Google (GOOGL.US) increased by 1.24% following a significant partnership with Apple to advance AI technology, with Google's Gemini model becoming a core support for future Apple devices [5] - Payment concept stocks continued to decline, with major banks also falling, amid concerns over potential impacts from proposed credit card interest rate caps [6] Group 6 - Intel (INTC.US) and AMD (AMD.US) saw initial gains of 7.33% and 6.39%, respectively, after KeyBanc Capital Markets upgraded their ratings to "overweight" [6] - Rezolve AI (RZLV.US) fell 9.23% despite raising its long-term revenue forecast, indicating significant commercialization progress [7] - Satellogic (SATL.US) declined 1.11% after a previous surge, following the announcement of a contract for two high-resolution satellites [7]

Core Viewpoint - Xunce (03317.HK) has seen a significant increase in its stock price, reaching a new high of 68 HKD during trading, reflecting strong market interest and performance [2] Group 1 - Xunce's stock price rose by over 6%, currently trading at 66.8 HKD, with a trading volume of 4.782 million HKD [2]

Core Viewpoint - XunCe (03317) has seen a significant increase in stock price, rising over 6% and reaching a new high of 68 HKD, driven by the announcement of a strategic cooperation framework agreement with Jin Yong Investment [1] Group 1: Strategic Cooperation - The strategic cooperation agreement with Jin Yong Investment is non-binding and aims to advance the development of real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] - The collaboration will focus on the innovation and commercialization of technology products related to wealth management, including the application of real-time data technology in smart valuation, risk monitoring, and compliance [1] - The partnership will explore investment opportunities in data infrastructure, artificial intelligence, and other fintech-related projects to foster a "data + capital" ecosystem [1] Group 2: Financial Implications - The board believes that the strategic cooperation with Jin Yong Investment will provide further opportunities for diversified revenue sources for the company [1] - The agreement is considered to be in the best interests of the company and its shareholders [1]

Core Viewpoint - XunCe (03317) continues to rise over 6%, reaching a new high of 68 HKD, driven by a strategic cooperation framework agreement with Jin Yong Investment aimed at enhancing digital transformation in investment research and wealth management [1] Group 1: Company Developments - XunCe's stock price increased by 6.88%, trading at 66.8 HKD with a transaction volume of 4.782 million HKD [1] - The company announced a non-binding strategic cooperation framework agreement with Jin Yong Investment on January 13 [1] Group 2: Strategic Goals - The strategic cooperation aims to advance real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] - The collaboration will promote innovation and commercialization of technology products related to wealth management, including applications of real-time data technology in smart valuation, risk monitoring, and compliance [1] - The partnership will explore investment opportunities in data infrastructure, artificial intelligence, and other fintech projects to cultivate a "data + capital" ecosystem [1] Group 3: Financial Implications - The board believes that the strategic cooperation with Jin Yong Investment will provide further opportunities for diversified revenue sources for the company [1] - The agreement is considered to be in the best interests of the company and its shareholders [1]

Core Viewpoint - Xunce (03317) continues to rise over 6%, reaching a new high of 68 HKD, with a current price of 66.8 HKD and a trading volume of 4.782 million HKD [1] Group 1: Strategic Cooperation - Xunce announced a non-binding strategic cooperation framework agreement with Jinyong Investment on January 13 [1] - The strategic cooperation aims to advance the development of real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] - The collaboration will promote innovation and commercialization of technology products related to wealth management, including applications of real-time data technology in smart valuation, risk monitoring, and compliance [1] Group 2: Business Development - The partnership will explore investment opportunities in data infrastructure, artificial intelligence, and other fintech-related projects to cultivate a "data + capital" ecosystem [1] - The board believes that the strategic cooperation with Jinyong Investment will provide further opportunities for diversified revenue sources for the company [1] - The agreement is considered to be in the best interests of the company and its shareholders [1]

Core Viewpoint - The company has entered into a non-binding strategic cooperation framework agreement with Jinyong Investment Limited to explore potential synergies and enhance its service offerings in the financial technology sector [1][3]. Group 1: Strategic Cooperation Objectives - The strategic cooperation aims to advance real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1][3]. - It seeks to promote innovation and commercialization of wealth management-related technology products, including the application of real-time data technology in smart valuation, risk monitoring, and compliance [1][3]. - The partnership will explore investment opportunities in data infrastructure, artificial intelligence, and other fintech-related projects to foster a "data + capital" ecosystem [1][3]. - Jinyong Investment may provide business services such as business development consulting, investment and financial consulting, cash management, and/or asset allocation services upon further agreements [1][3]. Group 2: Business Background - Jinyong Investment and its subsidiaries primarily engage in providing investment management services and conducting strategic direct investment activities [1][3]. - The board believes that the strategic cooperation will offer the company further opportunities for diversified revenue sources and is in the best interest of the company and its shareholders [1][3].